Terms: = Breast cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Staging
7 results:
1. Should the breast cancer staging System be Revised?
Sanli AN; Tekcan Sanli DE; Aydogan F; Altundag MK
Am Surg; 2024 May; 90(5):1066-1073. PubMed ID: 38128067
[TBL] [Abstract] [Full Text] [Related]
2. A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.
Liu W; Ye X; He L; Cheng J; Luo W; Zheng M; Hu Y; Zhang W; Cao Y; Ran H; Yang L
J Nanobiotechnology; 2021 Dec; 19(1):432. PubMed ID: 34930301
[TBL] [Abstract] [Full Text] [Related]
3. The Hypoxic Response Expression as a Survival Biomarkers in Treatment-Naive Advanced breast cancer.
Gunawan I; Hatta M; Benyamin AF; Islam AA
Asian Pac J Cancer Prev; 2020 Mar; 21(3):629-637. PubMed ID: 32212787
[TBL] [Abstract] [Full Text] [Related]
4. Genotyping analysis and ¹⁸FDG uptake in breast cancer patients: a preliminary research.
Bravatà V; Stefano A; Cammarata FP; Minafra L; Russo G; Nicolosi S; Pulizzi S; Gelfi C; Gilardi MC; Messa C
J Exp Clin Cancer Res; 2013 Apr; 32(1):23. PubMed ID: 23631762
[TBL] [Abstract] [Full Text] [Related]
5. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
Malfettone A; Saponaro C; Paradiso A; Simone G; Mangia A
BMC Cancer; 2012 Mar; 12():106. PubMed ID: 22439624
[TBL] [Abstract] [Full Text] [Related]
6. Expression of Hypoxia-inducible factor 1-α and vascular endothelial growth factor-C in locally advanced breast cancer patients.
Brito LG; Schiavon VF; Andrade JM; Tiezzi DG; Peria FM; Marana HR
Clinics (Sao Paulo); 2011; 66(8):1313-20. PubMed ID: 21915477
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.
Champion L; Brain E; Giraudet AL; Le Stanc E; Wartski M; Edeline V; Madar O; Bellet D; Pecking A; Alberini JL
Cancer; 2011 Apr; 117(8):1621-9. PubMed ID: 21472709
[TBL] [Abstract] [Full Text] [Related]
